The inhibition of JMJD1C conversely reduces cardiac hypertrophy and fibrosis induced by angiotensin II and decreases TIMP1 transcription with pro-fibrotic activity [40]. The gene discussed is JMJD1C; the disease is cardiac hypertrophy.